• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

十二指肠左旋多巴输注可改善晚期帕金森病患者的生活质量。

Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.

作者信息

Antonini A, Mancini F, Canesi M, Zangaglia R, Isaias I U, Manfredi L, Pacchetti C, Zibetti M, Natuzzi F, Lopiano L, Nappi G, Pezzoli G

机构信息

Parkinson Institute, Istituti Clinici di Perfezionamento, Milano, Italia.

出版信息

Neurodegener Dis. 2008;5(3-4):244-6. doi: 10.1159/000113714. Epub 2008 Mar 6.

DOI:10.1159/000113714
PMID:18322402
Abstract

BACKGROUND

A significant percentage of patients with Parkinson's disease (PD) continue to experience motor fluctuations and dyskinesias despite the association of dopamine agonists and levodopa with COMT or MAO-B inhibitors. The use of apomorphine infusion is limited by compliance while deep brain stimulation is feasible only for a small number of patients mostly because of age constraints.

OBJECTIVE

To assess prospectively the effectiveness of duodenal levodopa infusion on quality of life as well as motor features in patients with advanced PD. In all but 1 case levodopa infusion was stopped at nighttime.

METHODS

We report the outcome of 22 PD patients, followed for up to 2 years, who were on continuous duodenal levodopa/carbidopa infusion through percutaneous endoscopic gastrostomy.

RESULTS

We found a significant reduction in 'off' period duration as well as dyskinesia severity (Unified Parkinson's Disease Rating Scale part IV, items 33 and 39). There was significant improvement in the 39-item Parkinson's Disease Quality of Life Questionnaire as well as in the Unified Parkinson's Disease Rating Scale part II up to the 2-year follow-up. Five patients withdrew: 2 for poor compliance and 3 for adverse events (1 was related to percutaneous endoscopic gastrostomy).

CONCLUSIONS

These results demonstrate significant clinical improvements in quality of life and activities of daily living consistent with the occurrence of a satisfactory therapeutic response and a reduction in dyskinesia severity.

摘要

背景

尽管多巴胺激动剂以及左旋多巴与儿茶酚-O-甲基转移酶(COMT)或单胺氧化酶-B(MAO-B)抑制剂联合使用,但仍有相当比例的帕金森病(PD)患者持续出现运动波动和异动症。阿扑吗啡输注的应用受依从性限制,而深部脑刺激仅对少数患者可行,主要是因为年龄限制。

目的

前瞻性评估十二指肠左旋多巴输注对晚期PD患者生活质量以及运动特征的有效性。除1例患者外,所有患者夜间均停止左旋多巴输注。

方法

我们报告了22例接受经皮内镜下胃造口术持续十二指肠左旋多巴/卡比多巴输注的PD患者的随访结果,随访时间长达2年。

结果

我们发现“关”期时长以及异动症严重程度(统一帕金森病评定量表第四部分,项目33和39)显著降低。在长达2年的随访中,帕金森病生活质量问卷39项条目以及统一帕金森病评定量表第二部分均有显著改善。5例患者退出研究:2例因依从性差,3例因不良事件(1例与经皮内镜下胃造口术有关)。

结论

这些结果表明,生活质量和日常生活活动有显著临床改善,这与出现满意的治疗反应以及异动症严重程度降低相一致。

相似文献

1
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.十二指肠左旋多巴输注可改善晚期帕金森病患者的生活质量。
Neurodegener Dis. 2008;5(3-4):244-6. doi: 10.1159/000113714. Epub 2008 Mar 6.
2
Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.帕金森病空肠内左旋多巴输注:一项关于对非运动症状和生活质量影响的多中心试点研究
Mov Disord. 2009 Jul 30;24(10):1468-74. doi: 10.1002/mds.22596.
3
Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.十二指肠左旋多巴输注治疗晚期帕金森病:12个月治疗结果
Mov Disord. 2007 Jun 15;22(8):1145-9. doi: 10.1002/mds.21500.
4
Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of life.十八个月的连续十二指肠内左旋多巴输注治疗晚期帕金森病患者的研究:对波动控制和生活质量的影响。
Parkinsonism Relat Disord. 2010 Mar;16(3):218-21. doi: 10.1016/j.parkreldis.2009.07.015. Epub 2009 Sep 16.
5
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.晚期帕金森病中十二指肠左旋多巴输注单一疗法与口服多种药物联合治疗的比较
Neurology. 2005 Jan 25;64(2):216-23. doi: 10.1212/01.WNL.0000149637.70961.4C.
6
[Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].[司来吉兰在日常临床应用中。帕金森病患者联合治疗的研究结果]
Fortschr Neurol Psychiatr. 2008 Oct;76(10):594-9. doi: 10.1055/s-2008-1038249. Epub 2008 Oct 2.
7
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.晚期帕金森病患者的空肠内左旋多巴输注:对运动和非运动症状的长期影响及其对患者和照料者生活质量的影响。
Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):79-89.
8
[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].[多多巴持续多巴胺能刺激治疗晚期帕金森病:疗效与安全性]
Rev Neurol (Paris). 2009 Aug-Sep;165(8-9):718-27. doi: 10.1016/j.neurol.2008.11.017. Epub 2009 Jan 15.
9
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.普拉克索与左旋多巴作为帕金森病初始治疗的比较:一项4年的随机对照试验。
Arch Neurol. 2004 Jul;61(7):1044-53. doi: 10.1001/archneur.61.7.1044.
10
Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.晚期帕金森病中与生活质量相关的波动性功能:十二指肠左旋多巴输注的效果
Acta Neurol Scand. 2008 Dec;118(6):379-86. doi: 10.1111/j.1600-0404.2008.01049.x. Epub 2008 Jun 6.

引用本文的文献

1
Impact of Infusion Therapies on Quality of Life in Advanced Parkinson's Disease.输液疗法对晚期帕金森病患者生活质量的影响
Neuropsychiatr Dis Treat. 2023 Sep 14;19:1959-1972. doi: 10.2147/NDT.S422717. eCollection 2023.
2
Cross-Cultural Differences in Stigma Associated with Parkinson's Disease: A Systematic Review.跨文化差异与帕金森病相关耻辱感:系统评价。
J Parkinsons Dis. 2023;13(5):699-715. doi: 10.3233/JPD-230050.
3
Why do 'OFF' periods still occur during continuous drug delivery in Parkinson's disease?为什么在帕金森病的持续药物输送中仍会出现“关闭”期?
Transl Neurodegener. 2022 Oct 13;11(1):43. doi: 10.1186/s40035-022-00317-x.
4
Advanced Parkinson's Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis.左旋多巴卡比多巴肠凝胶用于晚期帕金森病治疗简化及长期疗效:COSMOS罗马尼亚亚组分析
Brain Sci. 2021 Nov 27;11(12):1566. doi: 10.3390/brainsci11121566.
5
Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶用于晚期帕金森病的患者及照料者结局
NPJ Parkinsons Dis. 2021 Nov 30;7(1):108. doi: 10.1038/s41531-021-00246-y.
6
Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life study.阿扑吗啡输注对晚期帕金森病的长期影响:一项真实世界研究。
NPJ Parkinsons Dis. 2021 Jun 11;7(1):50. doi: 10.1038/s41531-021-00194-7.
7
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.左旋多巴/卡比多巴肠凝胶对晚期帕金森病患者“关”期的长期影响:一项系统评价
Adv Ther. 2021 Jun;38(6):2854-2890. doi: 10.1007/s12325-021-01747-1. Epub 2021 May 20.
8
Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta-Analysis.将证据转化应用于晚期帕金森病患者:一项系统评价与荟萃分析
Mov Disord. 2021 Jun;36(6):1293-1307. doi: 10.1002/mds.28599. Epub 2021 Apr 2.
9
Intrajejunal vs oral levodopa-carbidopa therapy in Parkinson disease: A retrospective cohort study.帕金森病中经空肠内与口服左旋多巴-卡比多巴治疗的比较:一项回顾性队列研究。
Medicine (Baltimore). 2020 Nov 13;99(46):e23249. doi: 10.1097/MD.0000000000023249.
10
Long-Term Home-Monitoring Sensor Technology in Patients with Parkinson's Disease-Acceptance and Adherence.帕金森病患者的长期家庭监测传感器技术——接受度和依从性。
Sensors (Basel). 2019 Nov 26;19(23):5169. doi: 10.3390/s19235169.